PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Biochemistry, Center of Excellence in Molecular Biology and Regenerative Medicine (CEMR), JSS Academy of Higher Education & Research (JSS AHER), Mysore, India.\', \'AU College of Pharmaceutical Sciences, Andhra University, Visakhapatnam, India.\', \'Special Interest Group in Cancer Biology and Cancer Stem Cells (SIG-CBCSC), JSS Medical College, JSS Academy of Higher Education & Research (JSS AHER), Mysore, India.\', \'I. M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Moscow, Russia.\', \'Department of Normal and Topographic Anatomy, M.V. Lomonosov Moscow State University, Moscow, Russia.\', \'Research Institute of Human Morphology, Moscow, Russia.\', \'Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.\', \'Institute of Physiologically Active Compounds, Russian Academy of Sciences, Moscow, Russia.\', \'GALLY International Research Institute, San Antonio, TX, United States.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.3389/fimmu.2020.552925
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 33072093
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
is ?:relation_isRelatedTo_publication of
?:title
  • Strategies for Targeting SARS CoV-2: Small Molecule Inhibitors-The Current Status.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all